Anixa Biosciences Inc. (ANIX)
NASDAQ: ANIX
· Real-Time Price · USD
2.97
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.97
0.00%
After-hours: Aug 15, 2025, 07:56 PM EDT
Anixa Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
November - October.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 |
Net Income | -2.81M | -3.21M | -2.91M | -3.28M | -3.14M | -3.25M | -2.72M | -2.55M | -2.31M | -2.35M | -3.53M | -2.77M | -3.59M | -3.88M | -4.07M | -4.39M | -2.44M | -2.23M |
Depreciation & Amortization | 9K | -243K | 9K | 3K | 12K | 13K | 12K | 11K | 12K | 11K | 11K | 10K | 11K | 10K | 15.94K | 15.16K | 14.64K | 14.13K |
Stock-Based Compensation | 962K | 1.03M | 980K | 1.09M | 1.24M | 1.11M | 1.16M | 1.15M | 1.16M | 957K | 526K | 1.44M | 1.68M | 2.35M | 2.83M | 3.19M | 1.05M | 986.1K |
Other Working Capital | 456K | -751K | 513K | -502K | 428K | -329K | -600K | -23K | 175K | -453K | 681K | -213K | -62K | -50K | 249.09K | -65.36K | 203.29K | -212.31K |
Other Non-Cash Items | 199K | 24K | 24K | 144K | 1.22M | 154K | 25K | 17K | 25K | 25K | 680K | 8K | 64K | 1.96M | 633.59K | 3.39M | 1.12M | -5.45K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -633.59K | n/a | n/a | n/a |
Change in Working Capital | 140K | -503K | 973K | -607K | 452K | -292K | -488K | -125K | 261K | -708K | 719K | -78K | -474K | 318K | 177.56K | -295.64K | 129.49K | 67.14K |
Operating Cash Flow | -1.5M | -2.9M | -927K | -2.64M | -1.46M | -2.31M | -1.97M | -1.45M | -807K | -1.99M | -1.59M | -1.4M | -2.31M | -1.2M | -1.04M | -1.48M | -1.24M | -1.17M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -11.93M | n/a | -16.46M | -12.57M | -14.72M | -20.02M | -16.91M | -10.1M | -9.57M | -7.83M | -11.33M | -6.91M | -750K | -3.5M | -6.1M | -484 | -9.4M | -1M |
Sales Maturities Of Investments | 14.27M | 15.7M | 17.33M | 15.29M | 15.27M | 20.15M | 16.32M | 9.12M | 6.13M | 7.25M | 1.41M | 4M | 1M | 5.35M | 8.9M | 1M | 1M | 1.64M |
Other Investing Acitivies | n/a | -13M | n/a | n/a | n/a | 129K | -593K | -980K | -3.44M | -585K | -9.92M | -2.91M | 250K | 1.85M | 6.47K | 1M | -8.4M | 35.45K |
Investing Cash Flow | 2.34M | 2.7M | 867K | 2.72M | 556K | 129K | -593K | -980K | -3.44M | -585K | -9.92M | -2.91M | 250K | 1.85M | 2.81M | 999.52K | -8.4M | 675.45K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -384K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4K | -17K | 141K | 149K | 64K | 67K | 279K | 3K | 81K | 3K | -384K | 829K | 7K | n/a | n/a | n/a | -353 | 103.82K |
Financial Cash Flow | 18K | -17K | 106K | 149K | 897K | 2.26M | 279K | 3K | 81K | 3K | -384K | 829K | 7K | n/a | 143.62K | n/a | 25.36M | 6.06M |
Net Cash Flow | 857K | -218K | 46K | 230K | -3K | 83K | -2.28M | -2.42M | -4.17M | -2.57M | -11.89M | -3.48M | -2.05M | 653K | 1.91M | -481.25K | 15.72M | 5.57M |
Free Cash Flow | -1.5M | -2.9M | -927K | -2.64M | -1.46M | -2.31M | -1.97M | -1.45M | -807K | -1.99M | -1.59M | -1.4M | -2.31M | -1.2M | -1.04M | -1.48M | -1.24M | -1.17M |